ArticleJournal of medicinal chemistry2022

Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy.

John Fetse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.